Fostair now for maintenance and reliever therapy in asthma

Fostair (formoterol/beclometasone) can now be prescribed for patients with asthma who require maintenance and reliever therapy (MART).

Fostair delivers beclometasone as extra-fine particles so doses delivered are not bioequivalent to most other beclometasone inhaler formulations.
Fostair delivers beclometasone as extra-fine particles so doses delivered are not bioequivalent to most other beclometasone inhaler formulations.

MART should especially be considered for patients with uncontrolled asthma or with past exacerbations that have required medical attention. The recommended dosing regimen for Fostair in MART is one puff twice daily, with 1–2 additional puffs as needed up to a maximum of 8 puffs daily.

Evidence to support this regimen was provided by a 48-week parallel group study in 1701 patients with uncontrolled moderate to severe asthma. Patients were treated with the MART regimen or the standard maintenance regimen for Fostair (one puff twice daily plus concomitant salbutamol used as required). 

The MART regimen significantly prolonged the time to first severe exacerbation and the rate of severe exacerbations compared with the standard regimen (p<0.001 for both). Patients receiving MART also achieved a clinically meaningful improvement in asthma control.

View Fostair drug record
    
Further information: Chiesi Ltd

Follow MIMS on Twitter


Read these next

Fostair NEXThaler: extrafine dry powder inhaler launched for asthma

Fostair NEXThaler: extrafine dry powder inhaler launched for asthma

Fostair NEXThaler (formoterol/beclometasone) is the...

New COPD licence for Fostair

New COPD licence for Fostair

Fostair (formoterol/beclometasone) can now be prescribed...

Relvar Ellipta: combination inhaler for asthma and COPD

Relvar Ellipta: combination inhaler for asthma and COPD

Relvar Ellipta (vilanterol/fluticasone furoate) is...

Flo-Tone MDI: inhaler training device

Flo-Tone MDI: inhaler training device

Clement Clarke has launched Flo-Tone MDI, a dual spacer...

Flutiform: novel asthma combination inhaler

Flutiform: novel asthma combination inhaler

Flutiform (formoterol fumarate/fluticasone propionate)...


MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.